Drug Delivery

Most recent FDA COVID-19 updates

30-Jul-2020 By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

Lonza: the right bio model can make a difference

27-Jul-2020 By Jenni Spinner

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

Novartis launches NFP portfolio of COVID-19 treatments

21-Jul-2020 By Jenni Spinner

The company’s Sandoz division is offering 15 generic and OTC medicines to be sold at zero profit to low- and middle-income countries to treat the virus.

Aigenpulse launches AI-based discovery platform

20-Jul-2020 By Jenni Spinner

The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.

Syneos Health inks service deal with Pfizer

16-Jul-2020 By Jenni Spinner

The clinical development and consulting firm has signed a three-year service agreement to support the pharma firm with development service solutions.

Indegene: AI is transforming the pharma industry

14-Jul-2020 By Jenni Spinner

A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

Sandoz, Civica RX partner to stem shortage of generics

09-Jul-2020 By Jenni Spinner

The two companies plan to join forces in order to help healthcare providers anticipate and avoid shortages of critical injectable generic medications.

Webinar delves into drug delivery innovations

09-Jul-2020 By Jenni Spinner

Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.

Weekly FDA COVID-19 updates and actions

08-Jul-2020 By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.